top of page

Roche agrees to buy GenMark Diagnostics in US$1.8 billion deal

Roche will buy GenMark Diagnostics, a U.S.-based maker of molecular diagnostic tests in a US$1.8 billion deal, the Swiss pharmaceuticals manufacturer announces.
























































Comments

bottom of page